Industry Insights: AI 25th July
Industry Insights AI: 25/07/25 This week’s insights post focusses on the latest advancements in the application of artificial intelligence for disease detection. AI can help detect postoperative infections with accuracy Surgical site infections (SSIs) are a leading cause of postoperative complications. They often go undetected until symptoms worsen. A team of clinicians and scientists […]
Industry Insights: Healthcare 18th July
Industry Insights Healthcare: 18/07/25 In this week’s insights post, we discuss three of the most recent advancements and hot topics in the healthcare industry. Bringing sun exposure-related risks to light As UV (ultraviolet) Safety Awareness Month takes centre stage, healthcare professionals have once again reminded the public of the critical importance of sun safety. Excessive […]
Industry Insights: MedComms 11th July
Industry Insights MedComms: 11/07/25 This week’s post discusses three recent insights regarding regulatory writing tips, prompts for generative artificial intelligence (genAI) and careers in medical communications. Writing about medical devices as a regulatory writer In a recent interview posted by NetworkPharma.tv, Geneviève Laumen, freelance medical writer with a background in neuroscience and biology, shared […]
Industry Insights: AI 4th July
Industry Insights AI: 04/07/25 In this week’s insights post, we discuss some of the latest advancements in the applications of artificial intelligence in healthcare. FDA launches AI tool to improve scientific review The US Food and Drug Administration (FDA) has launched Elsa, an AI assistant designed to help staff complete scientific reviews faster and more […]
Industry Insights: Healthcare 27th June
Industry Insights Healthcare: 6/06/25 This week’s insights post discusses three of the most recent medication and device approvals in the healthcare industry. FDA approves new drug for COPD associated with eosinophilic inflammation The US Food and Drug Administration (FDA) has granted approval for GSK’s monoclonal antibody Nucala (mepolizumab) as an add-on maintenance treatment for adults […]
Industry Insights: MedComms 20th June
Industry Insights MedComms: 20/06/25 This round of insights in medical communications focusses on the key themes from the International Society for Medical Publication Professionals (ISMPP) Annual Meeting, held in Washington, DC on 12–14 May. Day 1: Diversity and innovation on centre stage The first day of the 21st Annual Meeting of the International Society […]
Industry Insights: AI 13th June
Industry Insights AI: 13/06/25 In this week’s insights post, we discuss some of the latest advancements in the applications of artificial intelligence in healthcare. FDA launches AI tool to improve scientific review The US Food and Drug Administration (FDA) has launched Elsa, an AI assistant designed to help staff complete scientific reviews faster and […]
Industry Insights: Healthcare 6th June
Industry Insights Healthcare: 6/06/25 This week’s insights post discusses three of the most recent medication and device approvals in the healthcare industry. FDA approves new drug for COPD associated with eosinophilic inflammation The US Food and Drug Administration (FDA) has granted approval for GSK’s monoclonal antibody Nucala (mepolizumab) as an add-on maintenance treatment for […]
Industry Insights: MedComms 30th May
Industry Insights MedComms: 30/05/25 In this round of insights in medical communications, we discuss three articles published in the latest edition of Medical Writing, a journal series published by the European Medical Writers Association (EMWA). This edition focusses on communicating about rare diseases. Regulatory writing for rare diseases In an interview published in Medical […]
Industry Insights: AI 23rd May
Industry Insights AI: 23/05/25 In this week’s insights post, we discuss some of the latest developments regarding the potential application of artificial intelligence (AI) tools in oncology care. Machine learning can recognise hydroxyurea resistance in blood cancer In a recent report published in Leukemia, researchers presented a machine learning (ML) model that can identify […]
Industry Insights: Healthcare 16th May
Industry Insights Healthcare: 16/05/25 In this week’s insights post, we elaborate on three of the most recent developments in the healthcare industry. Trump executive order aims to reduce US drug prices by 59% On 12 May 2025, US President Donald J. Trump signed an executive order to reduce prescription drug prices for American patients. […]
Industry Insights: MedComms 9th May
Industry Insights MedComms: 09/05/25 In this week’s medical communications post, we discuss three of the latest insights in the world of MedComms. Evaluating key performance indicators in healthcare marketing In a recent interview on NetworkPharma.tv, Dan Buckland, Director at Brandcast Health, discusses the importance of strategic thinking when assessing key performance indicators (KPIs) in healthcare […]
